Health Care

Federal prosecutors are set to announce a settlement with General Motors that resolves a criminal investigation into how the Detroit automaker concealed a deadly problem with small-car ignition switches, according to three people briefed on the case.

ConAgra Foods is likely to face a criminal charge now that the U.S. government has completed its investigation of the company's 2007 peanut butter recall.

Federal prosecutors are asking a judge to consider the "widespread harm" done by a nationwide salmonella outbreak in sentencing two egg industry executives whose company was responsible.

A federal grand jury in Texas has indicted the CEO of Minnesota-based medical device maker Vascular Solutions Inc. on charges he conspired to sell a varicose-vein treatment device for unapproved uses.

Chinese authorities have formally indicted two corporate investigators, an American and Briton, for allegedly illegally obtaining and selling private information.

GlaxoSmithKline posted an improvement in third-quarter core earnings; however, sales in China toppled 61%.

GlaxoSmithKline said some of its executives in China appeared to have breached Chinese law related to an ongoing bribery scandal. 

Chinese police accused GlaxoSmithKline of reportedly bribing officials and doctors by channeling money through travel agencies. 

GlaxoSmithKline has so far found no evidence of bribery in China related to past sales of Botox despite fresh allegations that it paid doctors cash and other benefits to prescribe the treatment.

The prostate cancer drug developer Dendreon is seeking Chapter 11 bankruptcy protection and says it has reached a financial restructuring agreement with investors holding more than $520 million in debt.

Prostate cancer drug developer Dendreon is seeking Chapter 11 bankruptcy protection with a plan that leads to either a sale of the company or a takeover by its lenders.

Spiders have forced Suzuki to recall more than 19,000 midsize cars.

Eli Lilly reaffirmed its financial goals, though it said getting there may require cost cutting due to patent expirations and other issues.

Novo Nordisk was handed an upgrade to 'buy' from 'hold' on Tuesday from Austria's Erste Group. 

Novo Nordisk was handed an upgrade to 'buy' from 'hold' on Tuesday from Austria's Erste Group. 

The pharmaceutical industry took a hit on Friday after Jefferies unleashed a bearish outlook on the sector and downgraded several of the major drug makers.

Rising health-care costs will likely create challenges for consumers and the retailers that depend on discretionary spending, new S&P research shows.

The medical device maker warned of weaker-than-expected quarterly sales amid shrinking medical robot revenue.

U.S. consumers denied the right to know the origin of their food by the WTO. 

Doris Ranzman had followed the expert advice, planning ahead in case she wound up unable to care for herself one day.